EVIDENCE-BASEDAWAITING CLINICIAN REVIEW

Amlodipine

WHO ATCC08CA01INNAmlodipine

Amlodipine is a long-acting dihydropyridine calcium-channel blocker. It is widely used once daily for hypertension and for prevention of angina symptoms, but it is not a rescue treatment for an acute episode of chest pain.

At a glance

Quick facts

Drug snapshot
Drug class
Dihydropyridine calcium-channel blocker
Main uses
Hypertension; chronic stable or vasospastic angina; selected coronary artery disease indications
Route
Oral
WHO ATC
C08CA01
Key safety
Peripheral oedema, dizziness, flushing and headache are common; excessive blood-pressure lowering and worsening angina after initiation or dose increase are uncommon but important.
Monitoring
Blood pressure, ankle oedema, symptoms of angina, liver impairment and interacting medicines.

Names & terminology

How this medicine may be named or searched

Canonical page name
Amlodipine
INN / generic name
Amlodipine
Aliases / salts
amlodipine · amlodipine besylate
Russian support entity
amlodipine.ru — entity relationship only, not a clinical source

Structured drug profile

Drug profile

INN data
INNAmlodipineInternational nonproprietary / generic name used for this entity.
WHO ATCC08CA01Anatomical Therapeutic Chemical classification; route-specific codes may differ for some medicines.
Drug classDihydropyridine calcium-channel blockerPharmacologic / therapeutic class.
MechanismBlocks L-type calcium channels predominantly in vascular smooth muscle, producing arterial vasodilation and lowering blood pressure.Mechanism summarized at reference level.
RouteOralAvailable routes depend on the specific product.
Main usesHypertension; chronic stable or vasospastic angina; selected coronary artery disease indicationsApproved indications can differ by country and formulation.
Key safety contextPeripheral oedema, dizziness, flushing and headache are common; excessive blood-pressure lowering and worsening angina after initiation or dose increase are uncommon but important.Check exact product labeling and patient-specific contraindications.
Monitoring / reviewBlood pressure, ankle oedema, symptoms of angina, liver impairment and interacting medicines.Monitoring depends on indication, dose, route and patient factors.

What is Amlodipine?

Amlodipine is a long-acting dihydropyridine calcium-channel blocker. It is widely used once daily for hypertension and for prevention of angina symptoms, but it is not a rescue treatment for an acute episode of chest pain.

What is Amlodipine used for?

Hypertension; chronic stable or vasospastic angina; selected coronary artery disease indications. The exact approved indication depends on the product, route and country. [1]

How it works

Blocks L-type calcium channels predominantly in vascular smooth muscle, producing arterial vasodilation and lowering blood pressure.

Forms and formulations

Tablets; oral liquid formulations are available in some markets. Different formulations may have different indications, strengths, excipients and instructions and should not be assumed interchangeable.

Country / market layer

Availability and formulations by market

Brand names, strengths, prescription status and approved uses vary by jurisdiction. Check the exact national product record before relying on a formulation.

Market-specific
🇬🇧
United KingdomSearch current eMC product information
Search eMC ↗

Availability depends on the active ingredient, route and formulation; not every medicine in this reference has a current UK product.

This English reference was selected because DiseasesConditions.org also maintains an entity relationship to the project’s Russian-language support site amlodipine.ru. The Russian site is not used as a clinical source for this page.

How it is used

Amlodipine is usually taken once daily with or without food. Dose selection depends on age, indication, response and comorbidity. Continue the prescribed regimen even when blood pressure feels normal unless a clinician changes it.

For prescription treatment, use the patient-specific regimen rather than copying a dose from another person or another formulation.

Side effects

Ankle swelling is characteristic and can be dose-related. Other effects include headache, flushing, palpitations, dizziness and fatigue. Severe hypotension or worsening chest pain needs clinical review.

Important warnings and monitoring

New severe chest pain, fainting, marked shortness of breath or rapidly worsening swelling warrants assessment. People with severe liver disease may need slower dose adjustment because amlodipine is metabolised hepatically.

Monitoring context: Blood pressure, ankle oedema, symptoms of angina, liver impairment and interacting medicines.

Interactions

Amlodipine has fewer interactions than many cardiovascular drugs, but CYP3A inhibitors can increase exposure. Simvastatin exposure can rise with amlodipine, so product labels impose dose limits in some markets.

Pregnancy and breastfeeding

Pregnancy and breastfeeding decisions should weigh maternal blood-pressure control against available safety data. Do not stop antihypertensive therapy simply because pregnancy is suspected; obtain prompt medical advice.

Overdose and accidental extra doses

Overdose can cause prolonged vasodilation, severe low blood pressure and shock. Significant extra dosing requires urgent poison-centre or emergency advice.

Practical clinical context

The most important distinction is between the medicine entity and a specific marketed product. Strength, salt, route, modified-release design, age authorization and prescription status can change between products. When safety or dosing decisions matter, use the exact package leaflet, prescribing information or national regulator record for the product actually being used.

This page deliberately separates general evidence from the project’s Russian-language support site amlodipine.ru; that site identifies the cross-language entity but is not treated as an authority for clinical claims.

Common questions

Frequently asked questions

AWAITING CLINICIAN REVIEW

Sources

Clinical statements in this reference are based on named public-health, regulatory or guideline sources. Product-specific labeling remains authoritative for exact indications, dosing and contraindications.

  1. 1. MedlinePlus. Amlodipine Drug Information. Source ↗
  2. 2. DailyMed. Amlodipine product labeling search. Source ↗

This medicine reference is evidence-based and is awaiting clinician review. It is not a substitute for personalized medical advice.